Scinai Immunotherapeutics Ltd.
SCNI · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $2 | $5 | $14 | $17 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $0 | $0 | $0 | $0 |
| Total Curr. Assets | $2 | $5 | $14 | $18 |
| Property Plant & Equip (Net) | $11 | $12 | $13 | $14 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $0 |
| Total NC Assets | $11 | $12 | $13 | $14 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $13 | $17 | $27 | $32 |
| Liabilities | – | – | – | – |
| Payables | $0 | $1 | $1 | $1 |
| Short-Term Debt | $0 | $1 | $0 | $1 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $1 | $0 | $1 | $1 |
| Total Curr. Liab. | $2 | $2 | $2 | $2 |
| LT Debt | $2 | $20 | $21 | $29 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $5 | $0 |
| Total NC Liab. | $2 | $20 | $26 | $29 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $2 | $1 | $1 | $2 |
| Total Liabilities | $3 | $22 | $29 | $31 |
| Equity | – | – | – | – |
| Pref Stock | $6 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$118 | -$122 | -$116 | -$110 |
| AOCI | -$2 | -$2 | -$2 | -$2 |
| Other Equity | $124 | $120 | $116 | $113 |
| Total Equity | $10 | -$5 | -$2 | $1 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $13 | $17 | $27 | $32 |
| Net Debt | $0 | $16 | $7 | $12 |